Inhibitor of Nek2Hec1
     
Home > PRODUCTS > Biochemicals > Inhibitor of Nek2Hec1

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.


Inhibitor of Nek2Hec1

N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]-4-pyridinecarboxamide

Inhibitor_of_Nek2Hec1

OTAVAchemicals Catalogue Number: 7070707072 
CAS Registry Number: 560103-80-2
Purity: 97%+

 
Ref.: Qiu et al. Synthesis and Biological Evaluation of a Series of Novel Inhibitor of Nek2/Hec1 Analogues. Journal of Medicinal Chemistry (2009), 52, 1757-1767


Abstract: High expression in cancer 1 (Hec1) is an oncogene overly expressed in many human cancers. Small molecule inhibitor of Nek2/Hec1 (INH) targeting the Hec1 and its regulator, Nek2, in the mitotic pathway, was identified to inactivate Hec1/Nek2 function mediated by protein degradation that subsequently leads to chromosome mis-segregation and cell death. To further improve the efficacy of INH, a series of INH analogues were designed, synthesized, and evaluated. Among these 33 newly synthesized analogues, three of them, 6, 13, and 21, have 6?8 fold more potent cell killing activity than the previous lead compound INH1. Compounds 6 and 21 were chosen for analyzing the underlying action mechanism. They target directly the Hec1/Nek2 pathway and cause chromosome mis-alignment as well as cell death, a mechanism similar to that of INH1. This initial exploration of structural/functional relationship of INH may advance the progress for developing clinically applicable INH analogue

 
SSL